A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
一项多中心 II 期临床试验，评估地西他滨作为一线治疗方案在不适合接受诱导化疗的老年急性髓系白血病患者中的疗效。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2011.048231
Lübbert, Michael; Rüter, Björn H; Claus, Rainer; Schmoor, Claudia; Schmid, Mathias; Germing, Ulrich; Kuendgen, Andrea; Rethwisch, Volker; Ganser, Arnold; Platzbecker, Uwe; Galm, Oliver; Brugger, Wolfram; Heil, Gerhard; Hackanson, Björn; Deschler, Barbara; Döhner, Konstanze; Hagemeijer, Anne; Wijermans, Pierre W; Döhner, Hartmut
